Rethinking the prosaicism of mosaicism; is it in us?

Experimental Dermatology

Volumn 19, Issue 12, 2010, Pages 1037-1039

  Cho, Raymond J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mosaicism; Mutation; Sequencing

Indexed keywords

DNA;

DNA SEQUENCE; EPIDERMAL NEVUS; EPIDERMIS; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HUMAN; KERATINOCYTE; MOSAICISM; NEVUS; NOTE;

CELL LINEAGE; CLONE CELLS; DISEASE; GENETIC ASSOCIATION STUDIES; HUMANS; KERATINS; MOSAICISM; MUTATION; NEOPLASMS; NEVUS; SEQUENCE ANALYSIS, DNA; SKIN; SKIN DISEASES;

EID: 78649494153     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01171.x     Document Type: Note

References (46)

1. Lacz N L, Schwartz R A, Kihiczak G. Int J Dermatol 2005: 44: 1-6.
2. Lane E B, McLean W H I. J Pathol 2004: 204: 355-366.
3. Abbasi N, Fangman W L, Rosenman K S et al. Pediatr Dermatol 2008: 25: 390-391.
4. Paller A S, Syder A J, Chan Y M et al. N Engl J Med 1994: 331: 1408-1415.
5. Happle R. Arch Dermatol 1993: 129: 1460-1470.
6. Jackson R. Br J Dermatol 1976: 95: 349-360.
7. -5)20, 000, or 43.8%.
8. Human Intermediate Filament Database. at
9. Dang N, Murrell D F. Exp Dermatol 2008: 17: 553-568.
10. Makkar H S, Frieden I J. Curr Opin Pediatr 2002: 14: 397-403.
11. Sezer E, Senayli A, Sezer T et al. J Dermatol 2006: 33: 635-638.
12. Consoli C, Moss C, Green S et al. J Invest Dermatol 2005: 125: 463-466.
13. Van Steensel M A M, Badeloe S, Winnepenninckx V et al. Exp Dermatol 2008: 17: 1057-1058.
14. Itin P H, Buechner S A. Am J Med Genet 1999: 85: 351-354.
15. Kehrer-Sawatzki H, Cooper D N. J Med Genet 2008: 45: 622-631.
16. Scheinfeld N S, Tarlow M M, Burgin S. Cutis 2002: 70: 73-75.
17. Ekmekci T R, Koslu A, Sakiz D. Eur J Dermatol 2005: 15: 73-74.
18. Teixeira M R, Ribeiro F R, Torres L et al. Br J Cancer 2004: 91: 775-782.
19. Fukino K, Shen L, Patocs A et al. JAMA 2007: 297: 2103-2111.
20. Tay Y K. Pediatr Dermatol 2008: 25: 410-411.
21. Haggstrom A N, Frieden I J. Am J Med Genet A 2008: 146A: 670-671.
22. Metry D W, Haggstrom A N, Drolet B A et al. Am J Med Genet A 2006: 140: 975-986.
23. Happle R. J Am Acad Dermatol 2007: 57: 690-699.
24. Parker C J. Hematology Am Soc Hematol Educ Program 2008: 93-103.
25. Holzelova E, Vonarbourg C, Stolzenberg M C et al. N Engl J Med 2004: 351: 1409-1418.
26. Uzel G, Tng E, Rosenzweig S D et al. Blood 2008: 111: 209-218.
27. Jonkman M F, Pasmooij A M G. N Engl J Med 2009: 360: 1680-1682.
28. McGrath J A. J Invest Dermatol 2004: 122: 73-77.
29. Gross M, Hanenberg H, Lobitz S et al. Cytogenet Genome Res 2002: 98: 126-135.
30. Wada T, Schurman S H, Otsu M et al. PNAS 2001: 98: 8697-8702.
31. Allison A C. Curr Opin Immunol 2009: 21: 499-505.
32. Piacentini L, Biasin M, Fenizia C et al. J Intern Med 2009: 265: 110-124.
33. Ansorge W J. N Biotechnol 2009: 25: 195-203.
34. Zhang K, Li J B, Gao Y, Egli D et al. Nat Methods 2009: 6: 613-618.
35. Park P J. Nat Rev Genet 2009: 10: 669-680.
36. Based on current costs for sequencing using Illumina sequencing-by-synthesis process using the HiSeq 2000 system. The calculated costs represent a single lane of sequence totaling more than 20 gigabases for 50 megabases of haploid target coding sequence, or approximately 400-fold oversampling.
37. Jones S, Hruban R H, Kamiyama M et al. Science 2009: 324: 217.
38. Zuo T, Wang L, Morrison C et al. Cell 2007: 129: 1275-1286.
39. Nelson D L. Curr Opin Genet Dev 2006: 16: 282-288.
40. Curatolo P, Bombardieri R, Jozwiak S. Lancet 2008: 372: 657-668.
41. Kwiatkowska J, Wigowska-Sowinska J, Napierala D et al. N Engl J Med 1999: 340: 703-707.
42. Niida Y, Stemmer-Rachamimov A O, Logrip M et al. Am J Hum Genet 2001: 69: 493-503.
43. Taipale J, Chen JK, Cooper MK et al. Nature 2000: 406: 1005-1009.
44. Smith F J D, Morley S M, McLean W H I. J Invest Dermatol 2004: 122: 73-77.
45. Jonkman M F, Castellanos Nuijts M, Van Essen A J. Clin Exp Dermatol 2003: 28: 625-631.
46. Gostynski A, Deviaene F C L, Pasmooij A M G et al. Br J Dermatol 2009: 161: 444-447.